Menu

BioCryst Pharmaceuticals, Inc. BCRX

Full chart Compare
Set alert

Price alert · BCRX

All alert types
7.69 USD +0.06 (+0.79%)

At closeNov 6, 2026, 4:20 PM EST

7.69 0.00 0.00%

After hours · Nov 6, 4:20 PM ET

7.38 Day range 7.83
6.23 52-week range 11.22
YTD
-1.41%
1 year
+9.39%

Ownership

Held by insiders 1.27%
Held by institutions 104.38%
Float held by institutions 105.72%
Institutions 411

Top institutional holders

Top institutional holders
Holder% heldSharesValueReported
Blackrock Inc.9.35%23,893,036183.62MJun 29, 2026
RA Capital Management, L.P.6.19%15,827,186121.63MJun 29, 2026
State Street Corporation5.94%15,191,098116.74MJun 29, 2026
Deerfield Management Company, L.P5.91%15,096,403116.02MJun 29, 2026
Vanguard Capital Management LLC4.45%11,364,23687.33MJun 29, 2026
Vanguard Portfolio Management LLC4.36%11,139,15885.60MJun 29, 2026

Top mutual fund holders

Top mutual fund holders
Holder% heldSharesValueReported
VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund3.16%8,067,36262.00MJun 29, 2026
SPDR SERIES TRUST-State Street SPDR S&P Biotech ETF2.70%6,891,00252.96MSep 29, 2026
iShares Trust-iShares Russell 2000 ETF2.27%5,791,33644.51MSep 29, 2026
VANGUARD INDEX FUNDS-Vanguard Small-Cap Index Fund1.14%2,911,46522.37MJun 29, 2026
VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund1.11%2,838,09721.81MJun 29, 2026
Fidelity Salem Street Trust-Fidelity Small Cap Index Fund0.99%2,542,17319.54MAug 30, 2026
BCRX insiders
InsiderRelationLatest transactionDateShares held
BARNES ALANE POfficerSaleMay 12, 2026400,703
DOYLE ANTHONYChief Financial OfficerStock Award(Grant)Dec 18, 2024377,867
GALSON STEVEN KDirectorStock Award(Grant)Jun 10, 202686,165
GAYER CHARLES KPresidentConversion of Exercise of derivative securityDec 21, 2025952,583
GHIAS BABARChief Financial OfficerStock Award(Grant)Dec 16, 2025268,700
HUTSON NANCY JDirectorStock Award(Grant)Jun 11, 202599,138